NCT07488195 · NOT YET RECRUITING
A Study Of Phototherapy In Patients With Dementia To Improve BPSD
Sponsor: Mayo Clinic
This trial is testing whether light therapy (phototherapy) can reduce behavioral and psychological symptoms of dementia, such as agitation. Participants are inpatients already admitted to a specific hospital unit with a dementia diagnosis. This is a Phase NA study, meaning it is likely a small feasibility or quality-improvement project rather than a large efficacy trial. Details on the light therapy protocol are limited so far.
You may qualify if
- Adult patients admitted on the inpatient Domitilla 3D or 4D unit.
- Documented diagnosis of dementia or suspected major neurocognitive disorder.
- Presence of BPSD symptoms either clinician documented in EHR or assessed through CMAI-O form
- Have patient consent or have a LAR able to sign the consent on behalf of the patient.
You're excluded if
- Macular degeneration, blindness, or photosensitivity
- Patients that do not have capacity to consent and do not have a legally authorized representative to consent on their behalf
- Recent eye surgery
- Bipolar disorder
- Pregnancy
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-10-26